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Background: Cystic fibrosis (CF) is considered to be a rare disease in Asians. We 
report two cases of CF in a 5-year-old girl and her newborn brother. They are of mixed 
parentage: a Taiwanese mother and an Australian father.
Methods: A comprehensive mutational analysis of the cystic fibrosis transmembrane 
conductance regulator (CFTR) gene was completed. Literature was reviewed for 
delta F508 in East Asians.
Results: Two mutation sites were identified in the siblings. The carrier status of their 
parents and elder brother were also confirmed: heterozygous delta F508 mutation 
from the father; 13 TG repeats in the IVS8-5T from the mother. An update of delta 
F508 mutation reported in East Asian patients from various ethnicities is included; 
most of them were of mixed parentage.
Conclusion: These two cases are the first report of cystic fibrosis associated with a 
delta F508 mutation in a Taiwanese patient attributable to a mutation most commonly 
seen in Caucasians. We found that the delta F508 mutation is of western origin. Asian 
patients are seldom found with this mutation unless they are of mixed parentage. 
Our findings provide further evidence that different ethnicities have their own set 
of CFTR mutations.
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Cystic fibrosis is the most common autosomal reces-
sive disorder in Caucasians, with an incidence of one 
in 2500 newborns.1 The disease is very rare in Asian 
populations. One study suggested that the incidence 
of CF is about one in 350,000 in the Japanese popula-
tion.2 Although the delta F508 mutation is the most 
common chromosomal mutation (in approximately 
70%) of CF and affected individuals in Caucasians and 
affected individuals (in nearly 90%),3 only six Asian 
patients have been associated with the delta F508 
genotype (including this study).4−6 Recent studies an-
alyzed healthy individuals in East Asia and found that 
none of them carried the delta F508 mutation of the 
CFTR gene.7−9 In this study, we report two siblings 
with cystic fibrosis; each had a heterozygous delta 
F508 mutation and non-classical phenotypes. They 
are the first cystic fibrosis cases with a delta F508 
mutation to be reported in Taiwan. We also reviewed 
other East Asian CF patients with delta F508 muta-
tions and their clinical and genetic manifestations.
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2. Materials and Methods
2.1. Patients and DNA extraction
The five family members (including the patients) 
donated blood for complete CFTR gene mutational 
analysis. Total genomic DNA was extracted from 
peripheral blood lymphocytes using a Puregene 
Blood Kit (Gentra Systems; Minneapolis, MN). Prepa-
rations were quantified spectrophotometrically by 
measuring absorbance at 260 nm and then stored 
at −20°C.
2.2.  Mutation detection by TTGE and 
sequencing
The primers used for the amplification of the 27 
coding sequences and exon-intron boundaries of 
the CFTR gene and PCR reaction were previously 
described in detail.10 PCR products were loaded 
onto the gel and temporal temperature gradient 
gel electrophoresis (TTGE) analysis was performed 
on a Bio-Rad D-Code apparatus (Bio-Rad Laboratories, 
Hercules, CA). The DNA samples that showed abnor-
mal banding on TTGE analysis were sequenced using 
a Big Dye terminator cycle sequencing kit (Applied 
Biosystems, Foster City, CA) and analyzed on an ABI 
Prism 3100 DNA Sequencer (Applied Biosystems). 
The mRNA (GenBank NM_000492.2) sequence of the 
CFTR gene was used as the reference sequence. 
Mutation nomenclature follows that used in previ-
ous reports as well as the Human Genome Variation 
Society (HGVS) guidelines.11
3. Case Report
The index case, a girl who was 5 years and 6 months 
old and living in central Taiwan, had been born to 
healthy nonconsanguineous mixed parentage: a 
Taiwanese mother and an Australian father. The par-
ents also had a 7-year-old son and a newborn boy. 
Neither of them had symptoms of CF. The 5-year-
old girl was referred from another hospital with a 
3-month history of dyspnea, recurrent bronchopul-
monary sputum with Pseudomonas areuginosa, a 
productive cough with thick, sticky mucus, and an 
intermittent fever of up to 39°C for 5 days prior to 
admission. On admission, she looked normal, had 
normal psychomotor development, was normally 
nourished, and had no steatorrhea. Her weight was 
20 kg (25−50th percentile) and her height was 125 cm 
(> 95th percentile). The mother’s weight was 52 kg 
and her height 164 cm, the father’s weight was 78 kg 
and his height 171 cm. Chest auscultation of the pa-
tient revealed mild rale and crackles in both lung 
fields and mild subcostal retraction. The abdomen 
was soft and flat. The liver and spleen were not 
palpable.
Laboratory findings revealed leukocytosis, with 
a white blood cell count of 19,500/mm3 (3% band 
cells, 71% segmented cells, and 14% lymphocytes). 
C-reactive protein was 5.1 mg/dL. Liver, pancreas 
and renal function tests were within normal limits 
(AST/ALT of 31/12 U/L, BUN/Cr of 4.1/0.4 mg/dL, 
amylase/lipase of 109/45 U/L, and α1 antitrypsin of 
141.7 mg/dL). The patient’s arterial blood gas anal-
ysis showed hypercapnia and respiratory acidosis 
with compensatory metabolic alkalosis. She had a 
serum chloride level of 106 mEq/L, a sodium level of 
141 mEq/L, and a potassium level of 4.0 mEq/L. Chest 
roentgenogram showed interstitial pneumonitis with 
focal parenchymal airspace consolidation in the left 
lower lung field (Figure 1A). High-resolution com-
puted tomography demonstrated peribronchial thick-
ening in both lungs. Peribronchovascular ground-glass 
nodular opacities and consolidations were evident 
in the right middle lobe and in both lower lobes 
(Figure 1B). The immunoglobulin (Ig) and IgA levels 
were slightly higher than normal (IgG 1001 mg/dL 
(normal 608−1572 mg/dL), IgA 262 mg/dL (normal 
33−236 mg/dL), IgM 108 mg/dL (normal 43−207 mg/
dL), reflecting a slight lung infection. The sputum 
culture grew P. areuginosa. Parenteral ceftazidime 
was given to treat the patient’s pulmonary infection. 
Her respiratory condition gradually improved and 
her febrile condition subsided after 4 days of anti-
biotic treatment. Ceftazidime was continued for a 
total of 2 weeks until P. areuginosa was eradicated 
from the sputum.
Her younger brother was a full-term newborn 
without any perinatal insult. He appeared normally 
nourished had normal gross motor and fine motor 
skills, and had no steatorrhea. His weight was 3.2 kg 
(25−50th percentile) and had a height of 53 cm (25−
50th percentile). Physical examination showed clear 
breathing sounds with a normal heart beat. The 
abdomen was soft and flat, and no hepatospleno-
megaly was noted.
Pilocarpine sweat test laboratory facilities are not 
available in Taiwan. DNA analysis was performed by 
direct sequencing of genomic DNA to screen the en-
tire CFTR gene and we found two mutation sites. 
One was c.1653_1655del 3bp in exon 10 of the CFTR 
gene, resulting in a deletion of phenylalanine at 
codon 508 (delta F508). The other was a sequence 
of 13TG repeats in the IVS8-5T of the CFTR gene. 
Se quence analysis of samples from members of her 
immediate family showed that the heterozygous delta 
F508 mutation was present on the CF chromosome of 
the father and elder brother, while the maternal chro-
mosome carried the 5T variant in IVS8. The patient’s 
younger brother had the same delta F508/IVS8-5T 
as the patient and CF was diagnosed (Figure 2).
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4. Discussion
More than 1500 different mutations have been 
identified in the CFTR gene.12 The most common 
one in European and North American populations is 
the delta F508; however, this mutation is very rare 
in Asian populations.13 Previous to this study, only 
four Asian patients with cystic fibrosis have been 
reported to carry the delta F508 CFTR mutation.4−6 
The clinical features of this mutation are summa-
rized in Table. Most of the patients were of mixed 
parentage, except for a Vietnamese male patient 
with unknown ancestry. Vietnam was a French col-
ony from 1858 to 1954; it is possible that the mu-
tation entered the Vietnamese gene pool through 
intermarriage in this 97-year period. A review of 
all genotypes of CF in South Asian Cana dian immi-
grants showed that delta F508 alleles were identi-
fied at a lower frequency (41% versus 66%) than in 
the worldwide CF population.14 Recent studies7−9 
screened for the delta F508 mutation in healthy 
East Asians (495 blood samples) from different 
A B
Figure 1 (A) Interstitial pneumonitis with focal parenchymal airspace consolidation in the left lower lung field. 
(B) Peribronchial thickening with peribronchovascular ground-glass nodular opacities and small consolidations.
The father (Australian) 45 y/o The mother (Taiwanese) 30 y/o 
Younger brother 2 m/o Our patient 5 y/oElder brother 7 y/o
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Figure 2 Family pedigree.
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backgrounds as well as in those with chronic pan-
creatitis (162 normal subjects and 65 patients) and 
congenital bilateral absence of the vas deferens 
(CBAVD) (36 patients); however, none of the indi-
viduals screened carried that mutation. Only one 
family in our observation provides evidence of the 
delta F508 mutation being of western origin (the 
Australian father). East Asian CF patients do not 
share common mutations such as delta F508 with 
individuals of other ethnic backgrounds.
Our patient had diffuse panbronchiolitis (DPB) 
and bronchopulmonary colonization with P. areugi-
nosa. Early onset of Pseudomonas infection in CF 
patients seemed to be common among Asians but 
rare in Caucasians,15 suggesting that genetic and 
environmental factors could play a role in the dif-
ferences in phenotypic presentation between Asians 
and Caucasians. Only pulmonary infection, not pan-
creatic insufficiency or failure to thrive was noted 
in our patients. CF should be recognized with only 
recurrent DPB, bronchiectasis or emphysema, even 
if the area has the low incidence rate of CF. A total 
of eight Taiwanese patients with CF have been 
reported;16 the high diversity of novel mutations 
suggest that these mutations probably arise from 
the population independently due to ran dom, spon-
taneous mutations in the CFTR gene. All patients 
presented with classical CF phenotypes, elevated 
sweat chloride levels and pancreatic insufficiency. 
We believe that the incidence of cystic fibrosis in 
Taiwan may be underestimated, with only patients 
with classic clinical presentation of cystic fibrosis 
having been diagnosed. Another possibility is that 
patients with mild symptoms such as a chronic 
cough may not have been presented since their 
parents may have ignored these symptoms.
Although the patient’s Australian father had delta 
F508 mutation and the Taiwanese mother had 
IVS8-5T, no CF patients within the parents’ families 
are diagnosed. Genetic consulting should be done for 
the carrier state of the parents’ families. The IVS8-5T 
mutation of the CFTR gene is found in 5%−10% of 
individuals in the general population.17 When a se-
vere CFTR mutation was found in a trans sequence, 
higher TG repeat numbers in IVS8-5T will result in 
re duced exon 9 splicing efficiency and, in some in-
stances, the reduction in full-length transcript will 
cause congenital bilateral absence of the vas def-
erens or non-classic CF or a normal phenotype.18 
A re cent study confirmed that those individuals 
with 5T adjacent to either 12 or 13 TG repeats 
were substantially more likely to exhibit a disease 
phenotype.14
A recent study reported that CF is rare among 
Taiwanese.16 Despite the low detection rate, the 
study will facilitate our understanding of CF patho-
genesis in the Taiwanese population. In conclusion, 
we are the first in Taiwan to report two siblings who 
carry the delta F508 mutation of CFTR gene com-
monly seen in Caucasians. The delta F508 mutation 
is of western origin. East Asian CF patients do not 
share common mutations such as delta F508 with 
individuals of other ethnic backgrounds. Our find-
ings provide further evidence that different eth-
nicities have their own set of CFTR mutations. The 
incidence of cystic fibrosis in Taiwan may be un-
derestimated, because undiagnosed CF patients may 
only have a pulmonary infection. Definitive molec-
ular diagnosis can confirm the non-typical clinical 
symptoms and facilitate treatment, and genetic 
counseling of the patient’s family.
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